Stage III Colorectal Cancer Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0071063 (Stage III Colorectal Cancer)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03095781Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal CancerTreatment